Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	33.1	19.34	18.26	16.51	0.12
Short-Term Investments	-	-	-	7.12	-
Cash & Short-Term Investments	33.1	19.34	18.26	23.63	0.12
Cash Growth	71.14%	5.91%	-22.70%	19954.27%	-86.78%
Other Receivables	0.23	0.19	0.09	0.34	0.49
Receivables	0.23	0.19	0.09	0.34	0.49
Prepaid Expenses	1.11	0.27	0.24	0.21	0.29
Total Current Assets	34.44	19.8	18.59	24.18	0.89
Property, Plant & Equipment	0.42	0.46	0.53	0.47	0.25
Other Long-Term Assets	0.08	0.01	0	0.02	-
Total Assets	34.94	20.27	19.12	24.67	1.14
Accrued Expenses	3.01	3.87	2.91	1.67	2.38
Short-Term Debt	-	-	-	-	9.82
Current Portion of Long-Term Debt	-	10.4	0.08	0.08	-
Current Portion of Leases	0.07	0.05	0.05	0.05	0.04
Current Income Taxes Payable	-	0.04	-	-	-
Other Current Liabilities	0.02	5.02	0.02	0	5.44
Total Current Liabilities	3.1	19.37	3.06	1.79	17.69
Long-Term Debt	-	-	8.8	7.66	-
Long-Term Leases	-	-	0.05	0.11	0.16
Other Long-Term Liabilities	-	-	-	-	0.3
Total Liabilities	3.1	19.37	11.91	9.56	18.14
Common Stock	116.36	92.91	71	61.36	18.68
Additional Paid-In Capital	20.5	17.51	16.85	-	4.86
Retained Earnings	-131	-105.5	-77.28	-58.68	-40.18
Comprehensive Income & Other	-4.16	-2.71	-2.79	13.09	-
Total Common Equity	1.7	2.22	7.79	15.77	-16.65
Minority Interest	-1.57	-1.32	-0.58	-0.66	-0.36
Shareholders' Equity	31.84	0.89	7.21	15.11	-17
Total Liabilities & Equity	34.94	20.27	19.12	24.67	1.14
Total Debt	0.07	10.45	8.99	7.9	10.02
Net Cash (Debt)	33.03	8.89	9.28	15.73	-9.9
Net Cash Growth	271.55%	-4.18%	-41.03%	-	-
Net Cash Per Share	0.97	0.37	0.48	1.27	-1.62
Filing Date Shares Outstanding	35.85	35.62	27.36	14.24	12.87
Total Common Shares Outstanding	35.64	27.28	21.59	14.24	6.18
Working Capital	31.33	0.43	15.53	22.39	-16.8
Book Value Per Share	0.05	0.08	0.36	1.11	-2.69
Tangible Book Value	1.7	2.22	7.79	15.77	-16.65
Tangible Book Value Per Share	0.05	0.08	0.36	1.11	-2.69
Buildings	-	-	-	0.07	0.07
Machinery	0.7	0.68	0.61	0.1	0.07
Leasehold Improvements	0.12	0.13	0.13	0.13	0.08

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q